These three Pharma stocks should be on your radar today; Key factors explained

December 24, 2025
Uncategorized

While both Ajanta Pharma and Zydus Life inked licensing deals, Emcure Pharma’s unit has received an establishment inspection report (EIR) from the US Drug Regulator.

These three Pharma stocks should be on your radar today; Key factors explained

Leave a ReplyCancel Reply

Vedant Fashions shares fall after 38% target cut; analysts warn of further derating

Kwality Walls shares list at 26% discount after HUL demerger

Rupee slips marginally to 90.67 against US dollar in early session

Explained: Why Natco Pharma shares surged 11% today

F&O volumes may fall 15-20% after RBI funding curbs: HDFC Securities